TAE Technologies

What TAE Technologies does

TAE Technologies, founded in 1998 and headquartered in Foothill Ranch, California, is a pre-revenue fusion energy company developing commercial power plants using a proprietary advanced beam-driven Field-Reversed Configuration (FRC) approach with aneutronic hydrogen-boron (p-B11) fuel. The company's plasma confinement technology uses neutral particle accelerator beams to inject high-energy particles into plasma, driving the self-generated magnetic field that produces confinement and stability. The fuel cycle produces only helium as a byproduct, with no long-lived radioactive waste or meltdown risk, and the company's Norm machine demonstrated FRC plasma generation using only neutral beam injection, reducing required hardware by approximately 50% compared with prior generations. TAE has built five generations of fusion devices since 1998, with plasma temperatures exceeding 70 million degrees Celsius on the Norman reactor, and targets initial 50 MWe commercial deployment (Da Vinci prototype) in the early 2030s scaling to 350–500 MWe future plants.

The company operates three business units alongside its core fusion program: TAE Fusion Power (the core hydrogen-boron commercial fusion effort), TAE Power Solutions (commercializing power management innovations, including ultrafast pulse charging and modular ACi technology, for e-mobility and battery energy storage), and TAE Life Sciences (developing Boron Neutron Capture Therapy (BNCT) cancer treatment using the Alphabeam neutron source system licensed from fusion research). Target customers span electric utilities and grid operators seeking dispatchable carbon-free baseload, hyperscale AI data center operators facing surging electricity demand, carbon-intensive industrial users requiring high-temperature process heat, and hospital systems for BNCT oncology applications. Distribution occurs through direct enterprise engagement, strategic partnerships with the UK Atomic Energy Authority (TAE Beam UK joint venture), and government collaborations with U.S. national laboratories, ITER, and Japan's National Institute for Fusion Science.

TAE's go-to-market is enterprise-direct sales targeting utility-scale deployments, supplemented by deep collaborations with strategic technology partners including Google (machine learning for plasma control since 2014), Chevron (strategic investor), and Goldman Sachs (financial advisor). The company has raised over $1.3 billion in private capital across multiple funding rounds and announced a $6 billion all-stock merger with Trump Media & Technology Group in December 2025, expected to close in mid-2026 and create one of the first publicly traded fusion companies. Senior commercial leadership additions, including a President/COO from ExxonMobil and CFO from Occidental Petroleum, signal a transition from R&D-led organization to commercially-scaling energy developer.

Name

TAE Technologies

Legal name

TAE Technologies, Inc.

Website

https://tae.com/

Company type

Private

Founded year

1998

Operating status

Operating

Headcount range

251–500 employees

Short description

TAE Technologies is a pre-revenue fusion energy company developing commercial hydrogen-boron power plants using advanced beam-driven Field-Reversed Configuration plasma confinement, targeting electric utilities, AI data center operators, and industrial customers, with subsidiary operations in power management and BNCT cancer therapy.

Ownership category

akta.pro rank

Product category

Fusion Energy / Clean Power Generation

NAICS

Nuclear Electric Power Generation (221113), Turbine and Turbine Generator Set Units Manufacturing (333611)

SIC

Engines & Turbines (3510), Cogeneration Services & Small Power Producers (4991), Power, Distribution & Specialty Transformers (3612)

akta.pro primary industry

Gen III/III+ Reactor Systems & Components (EUAKADAB)

akta.pro secondary industries

High-Voltage & High-Power Conversion (HVDC supplies, traction/rail converters, large rectifiers) (IMAGADAH), DC-DC Converters & Power Modules (Isolated/non-isolated, POL modules) (IMAGADAB)

Keywords

• Fusion power generation
• Hydrogen boron fuel
• Beam driven plasma
• Power management systems
• Neutron capture therapy

Headquarters

HQ city

Foothill Ranch

HQ country

United States

HQ region

North America

Offices4 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Operations, Infrastructure, Supply Chain

Revenue model

1. Fusion Power Plant Deployment: Pre-revenue company developing commercial fusion power plants. Expected to generate electricity for utilities and AI data centers upon commercialization in the early 2030s.
2. TAE Life Sciences - BNCT Cancer Treatment: Biotechnology subsidiary developing Boron Neutron Capture Therapy (BNCT) using proprietary Alphabeam neutron source for cancer treatment in hospital settings.
3. TAE Power Solutions: Subsidiary commercializing power management innovations for e-mobility and battery energy storage systems, including ultrafast pulse charging technology and modular ACi technology.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels7 records

Core offering

TAE Technologies develops commercial fusion power plants using proprietary advanced beam-driven Field-Reversed Configuration (FRC) technology with hydrogen-boron (p-B11) aneutronic fuel. The company is advancing a roadmap of fusion devices (Norman, Norm, Da Vinci) toward utility-scale power plants targeting the early 2030s. Through its subsidiaries, TAE also commercializes power management innovations for e-mobility and battery storage (TAE Power Solutions) and Boron Neutron Capture Therapy systems for cancer treatment (TAE Life Sciences).

Product overview

TAE Technologies operates as a unified fusion energy company with three primary business units: TAE Fusion Power (core fusion power technology using hydrogen-boron advanced beam-driven FRC), TAE Power Solutions (power management for e-mobility and battery storage commercialized from fusion research), and TAE Life Sciences (cancer treatment using Boron Neutron Capture Therapy). The company's fusion development roadmap includes Norman (5th generation device), Norm (compact breakthrough prototype), and Da Vinci (first commercial power plant prototype targeting early 2030s). The company also operates TAE Beam UK, a joint venture with UKAEA for neutral beam commercialization.

Differentiator

Problem solved

Functional benefit

Brands

• TAE Fusion Power: Core fusion power business developing hydrogen-boron commercial fusion energy
• TAE Power Solutions
• TAE Life Sciences

Products and services

• TAE Fusion Power Commercial fusion power solution using hydrogen-boron (p-B11) fuel via advanced beam-driven Field-Reversed Configuration technology, designed to produce clean, safe, carbon-free electricity without radioactive waste or meltdown risk for utility-scale customers.
• Norman (C-2W) Fusion Device Fifth-generation FRC fusion device and world's largest compact-toroid device, demonstrating plasma confinement at 30+ million degrees Celsius and ultimately exceeding 70 million degrees Celsius through AI-driven plasma control.
• Norm Fusion Prototype Compact fusion prototype that produces FRC plasma using only neutral beam injection, leapfrogging planned sixth device Copernicus with approximately 50% less hardware, planned to operate at 100 million degrees Celsius.
• Da Vinci Prototype Power Plant First prototype commercial fusion power plant designed to deliver net electricity to the grid, targeting initial 50 MWe capacity with planned scaling to 350-500 MWe for future commercial deployments.
• TAE Power Solutions Commercializes power management innovations derived from fusion R&D for e-mobility and battery energy storage systems, including ultrafast pulse charging technology and modular ACi technology for peak power output and extended battery life.
• TAE Life Sciences Biotechnology company developing Boron Neutron Capture Therapy (BNCT) for cancer treatment using particle accelerator technology licensed from TAE's fusion research, targeting head/neck cancers and glioblastoma multiforme.
• Alphabeam Neutron System Compact, hospital-installable neutron source system delivering cellular-level targeted radiation therapy based on Boron Neutron Capture Therapy (BNCT) for difficult-to-treat cancers.
• TAE Beam UK Joint venture with UKAEA focused on commercializing neutral beam particle accelerator technology for fusion energy and adjacent applications including cancer therapeutics, food safety, and homeland security.

Quantifiable outcome

• Achieved plasma temperatures exceeding 70 million degrees Celsius, surpassing original goal by 250%
• +2 more outcomes

Named customers1 record

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Six partnerships are on record, tiered core and major.

• National Institute for Fusion Science (Japan)coreStrategic or Co-development Partner · 2 December 2025Collaboration on hydrogen-boron fusion experiments to gain insights for TAE's commercial fusion concept. Joint publication in Nuclear Fusion journal on innovative heating methods combining radio frequency waves with neutral particle beams.
• UK Atomic Energy Authority (UKAEA)coreStrategic or Co-development Partner · 14 May 2025Joint venture TAE Beam UK formally established in the UK, fully funded, operating out of Culham Campus. Focuses on commercializing neutral beam particle accelerator technology for fusion and non-fusion applications including cancer therapeutics, food safety, and homeland security.
• ITER OrganizationmajorStrategic or Co-development Partner · 1 November 2024TAE signed cooperation agreement with ITER as part of Private Sector Fusion Engagement (PSFE) project, fostering collaboration between international public fusion project and private sector startups.
• Lawrence Berkeley National LaboratorycoreStrategic or Co-development PartnerPartnership implementing upgraded Darwin plasma simulation model into open-source WarpX code for simulating plasma performance.
• University of California, IrvinecoreStrategic or Co-development PartnerOrigin of TAE's technology development in the 1990s; continued collaboration in plasma physics and fusion research.
• National Laboratories (LLNL, LANL, ORNL, PPPL, MIT)majorStrategic or Co-development PartnerCollaborations with US national laboratories and MIT for fusion research, materials science, and technology development.

Scale indicators7 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Commonwealth Fusion Systems: Commonwealth Fusion Systems is a leading private fusion energy company pursuing a tokamak approach using high-temperature superconducting magnets. Most directly comparable to TAE: similar funding scale (>$2B raised), similar target customer segments (utilities, data centers), and a comparable pre-commercial R&D timeline. Key differentiation is the tokamak vs. FRC plasma confinement architecture.
• Helion Energy: Helion is a direct fusion energy competitor developing a pulsed field-reversed configuration approach with direct electricity conversion. Comparable to TAE in targeting hyperscaler PPAs (Microsoft), pursuing non-tokamak plasma confinement, and operating at similar pre-commercial scale with substantial venture funding.
• Tokamak Energy: Tokamak Energy is a UK-based fusion company developing spherical tokamak technology using high-temperature superconducting magnets. Comparable to TAE in pursuing compact fusion, targeting utility-scale deployments, and operating in the UK with government/national laboratory partnerships (UKAEA).
• General Fusion: General Fusion is a Canadian magnetized target fusion company pursuing a steam-piston-driven compression approach. Comparable to TAE in pursuing non-tokamak alternative fusion approaches, targeting utility power generation, and operating at a similar pre-commercial R&D scale.
• Zap Energy: Zap Energy is a US fusion startup developing sheared-flow Z-pinch confinement, an alternative plasma confinement approach. Comparable to TAE in pursuing compact, cost-efficient non-tokamak fusion designs targeting commercial power generation, at a similar pre-commercial stage with venture backing.
• Type One Energy: Type One Energy is pursuing stellarator-based fusion using high-field superconducting magnets. Comparable to TAE as a private fusion energy competitor targeting utility-scale commercial power, with similar pre-revenue R&D timelines and alternative confinement architecture.

Emerging players

• Xcimer Energy: Xcimer Energy is an emerging inertial fusion energy startup pursuing laser-driven fusion with a mercury target chamber. Comparable to TAE in targeting commercial fusion power generation at utility scale but at an earlier funding stage with a fundamentally different (inertial confinement) technical approach.
• Neutron Therapeutics: Neutron Therapeutics manufactures in-hospital neutron beam systems for Boron Neutron Capture Therapy (BNCT) cancer treatment. Directly comparable to TAE Life Sciences, which develops the Alphabeam neutron system for the same clinical application and customer base.
• TAE Technologies peer: Avalanche Energy: Avalanche Energy is an emerging compact fusion startup pursuing Orbitron fusion technology for distributed, smaller-scale power generation. Comparable to TAE in pursuing non-tokamak compact fusion but at a much earlier funding and development stage, targeting a smaller distributed-power use case.

Broad incumbents

• Fluence Energy: Fluence Energy is a publicly traded leader in utility-scale battery energy storage systems and grid-scale power management. Comparable to TAE's TAE Power Solutions subsidiary which commercializes power management innovations for battery storage and e-mobility applications.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/tae
• YouTubeyoutube.com/channel/UC-LHpK7z8vjMq2-pt4wG4ug
• Facebookfacebook.com/TAE
• LinkedInlinkedin.com/company/tae-technologies-inc
• Instagraminstagram.com/tae_technologies

Revenue estimate

Valuation estimate

Number of profiles

Profiles25 records

Subsidiaries3 records

Funding overview

Funding rounds19 records

Investors16 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about TAE Technologies